Neuroscientific Biopharmaceuticals (ASX:NSB) Total Assets : A$3.93 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals Total Assets?

Neuroscientific Biopharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 was A$3.93 Mil.

During the past 12 months, Neuroscientific Biopharmaceuticals's average Total Assets Growth Rate was 19.40% per year. During the past 3 years, the average Total Assets Growth Rate was -5.60% per year.

During the past 5 years, Neuroscientific Biopharmaceuticals's highest 3-Year average Total Assets Growth Rate was 0.50%. The lowest was -5.60%. And the median was -2.55%.

Total Assets is connected with ROA %. Neuroscientific Biopharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 was -53.37%. Total Assets is also linked to Revenue through Asset Turnover. Neuroscientific Biopharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Neuroscientific Biopharmaceuticals Total Assets Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Total Assets Chart

Neuroscientific Biopharmaceuticals Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

5.12

3.74

14.83

7.74

5.29

Neuroscientific Biopharmaceuticals Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial							10.06	7.74	3.82	5.29	3.93

Neuroscientific Biopharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Neuroscientific Biopharmaceuticals's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	4.694	+	0.597
	=	5.29

Neuroscientific Biopharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	3.81	+	0.118
	=	3.93

Neuroscientific Biopharmaceuticals (ASX:NSB) Total Assets Explanation

Total Assets is connected with ROA %.

Neuroscientific Biopharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-2.46	/	( (5.291	+	3.928)	/ 2 )
	=	-2.46	/	4.6095
	=	-53.37 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Neuroscientific Biopharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (5.291	+	3.928)	/ 2 )
=	0	/	4.6095
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Neuroscientific Biopharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011

Website

https://www.neuroscientific.com

Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines